Christopher P Schwartz
Examiner (ID: 16053, Phone: (571)272-7123 , Office: P/3657 )
Most Active Art Unit | 3657 |
Art Unit(s) | 3683, 3613, 3657, 3103 |
Total Applications | 3838 |
Issued Applications | 3193 |
Pending Applications | 171 |
Abandoned Applications | 289 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5705691
[patent_doc_number] => 20060194739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Nociceptin-based analgesics'
[patent_app_type] => utility
[patent_app_number] => 11/402083
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 9604
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 51
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194739.pdf
[firstpage_image] =>[orig_patent_app_number] => 11402083
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/402083 | Nociceptin-based analgesics | Apr 10, 2006 | Abandoned |
Array
(
[id] => 823708
[patent_doc_number] => 07405199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-29
[patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/233220
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17690
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/405/07405199.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233220
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233220 | Cross-linked glycopeptide-cephalosporin antibiotics | Sep 21, 2005 | Issued |
Array
(
[id] => 5814033
[patent_doc_number] => 20060084130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Method for diagnosing a transmissible spongiform subacute encephalopathy caused by an unconventional transmissible agent strain in a biological sample'
[patent_app_type] => utility
[patent_app_number] => 11/224951
[patent_app_country] => US
[patent_app_date] => 2005-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7924
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084130.pdf
[firstpage_image] =>[orig_patent_app_number] => 11224951
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/224951 | Method for diagnosing a transmissible spongiform subacute encephalopathy caused by an unconventional transmissible agent strain in a biological sample | Sep 13, 2005 | Issued |
Array
(
[id] => 5656450
[patent_doc_number] => 20060142186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/179608
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4523
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142186.pdf
[firstpage_image] =>[orig_patent_app_number] => 11179608
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/179608 | Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease | Jul 12, 2005 | Abandoned |
Array
(
[id] => 5821033
[patent_doc_number] => 20060025346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Permeability enhancer'
[patent_app_type] => utility
[patent_app_number] => 11/171551
[patent_app_country] => US
[patent_app_date] => 2005-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4400
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025346.pdf
[firstpage_image] =>[orig_patent_app_number] => 11171551
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/171551 | Permeability enhancer | Jun 30, 2005 | Abandoned |
Array
(
[id] => 856819
[patent_doc_number] => 07375078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'Heterocyclic self-immolative linkers and conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/064785
[patent_app_country] => US
[patent_app_date] => 2005-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21920
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/375/07375078.pdf
[firstpage_image] =>[orig_patent_app_number] => 11064785
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/064785 | Heterocyclic self-immolative linkers and conjugates | Feb 21, 2005 | Issued |
Array
(
[id] => 5678325
[patent_doc_number] => 20060183681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Stabilized compositions containing natriuretic peptides'
[patent_app_type] => utility
[patent_app_number] => 11/058465
[patent_app_country] => US
[patent_app_date] => 2005-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4282
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183681.pdf
[firstpage_image] =>[orig_patent_app_number] => 11058465
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/058465 | Stabilized compositions containing natriuretic peptides | Feb 13, 2005 | Abandoned |
Array
(
[id] => 7149560
[patent_doc_number] => 20050120397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Compounds and methods for regulation of spermatid differentiation'
[patent_app_type] => utility
[patent_app_number] => 10/993167
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19197
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20050120397.pdf
[firstpage_image] =>[orig_patent_app_number] => 10993167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/993167 | Compounds and methods for regulation of spermatid differentiation | Nov 21, 2004 | Abandoned |
Array
(
[id] => 737513
[patent_doc_number] => 07033997
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 10/989397
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 1658
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/033/07033997.pdf
[firstpage_image] =>[orig_patent_app_number] => 10989397
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/989397 | Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections | Nov 16, 2004 | Issued |
Array
(
[id] => 668520
[patent_doc_number] => 07094761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-22
[patent_title] => 'Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions'
[patent_app_type] => utility
[patent_app_number] => 10/977810
[patent_app_country] => US
[patent_app_date] => 2004-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 18833
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094761.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977810
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977810 | Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions | Oct 27, 2004 | Issued |
Array
(
[id] => 7111676
[patent_doc_number] => 20050209132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 10/967578
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17646
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209132.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967578 | Cross-linked glycopeptide-cephalosporin antibiotics | Oct 17, 2004 | Issued |
Array
(
[id] => 7609792
[patent_doc_number] => 06998397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-14
[patent_title] => 'Method for decreasing cholesterol level in blood'
[patent_app_type] => utility
[patent_app_number] => 10/710613
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3911
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/998/06998397.pdf
[firstpage_image] =>[orig_patent_app_number] => 10710613
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/710613 | Method for decreasing cholesterol level in blood | Jul 22, 2004 | Issued |
Array
(
[id] => 7056409
[patent_doc_number] => 20050277584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Pharmaceutical compositions comprising cyclosporins'
[patent_app_type] => utility
[patent_app_number] => 10/865638
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2619
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277584.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865638
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865638 | Pharmaceutical compositions comprising cyclosporins | Jun 8, 2004 | Abandoned |
Array
(
[id] => 720161
[patent_doc_number] => 07049298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Flavor-active peptides'
[patent_app_type] => utility
[patent_app_number] => 10/812088
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3788
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049298.pdf
[firstpage_image] =>[orig_patent_app_number] => 10812088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/812088 | Flavor-active peptides | Mar 29, 2004 | Issued |
Array
(
[id] => 833523
[patent_doc_number] => 07396812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-08
[patent_title] => 'Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof'
[patent_app_type] => utility
[patent_app_number] => 10/551040
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 27
[patent_no_of_words] => 11321
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396812.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551040 | Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof | Mar 28, 2004 | Issued |
Array
(
[id] => 7672962
[patent_doc_number] => 20040180817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Neuropathologies associated with expression of tnf-$g (a)'
[patent_app_type] => new
[patent_app_number] => 10/473994
[patent_app_country] => US
[patent_app_date] => 2004-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10568
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473994 | Neuropathologies associated with expression of tnf-$g (a) | Mar 2, 2004 | Abandoned |
Array
(
[id] => 7261540
[patent_doc_number] => 20040241197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Cosmetic or dermatological preparations including creatinine or a derivative thereof and creatine or a derivative thereof and methods of applying the preparations to the skin'
[patent_app_type] => new
[patent_app_number] => 10/767962
[patent_app_country] => US
[patent_app_date] => 2004-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6498
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241197.pdf
[firstpage_image] =>[orig_patent_app_number] => 10767962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/767962 | Cosmetic or dermatological preparations including creatinine or a derivative thereof and creatine or a derivative thereof and methods of applying the preparations to the skin | Jan 25, 2004 | Abandoned |
Array
(
[id] => 655153
[patent_doc_number] => 07109291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-19
[patent_title] => 'Compounds capable of modulating the activity and stimulating the production of a catalytic antibody'
[patent_app_type] => utility
[patent_app_number] => 10/716030
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6081
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/109/07109291.pdf
[firstpage_image] =>[orig_patent_app_number] => 10716030
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/716030 | Compounds capable of modulating the activity and stimulating the production of a catalytic antibody | Nov 16, 2003 | Issued |
Array
(
[id] => 7238248
[patent_doc_number] => 20040157772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis'
[patent_app_type] => new
[patent_app_number] => 10/477775
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3359
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157772.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477775
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477775 | Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis | Nov 13, 2003 | Abandoned |
Array
(
[id] => 7336696
[patent_doc_number] => 20040132642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Methods of inhibiting metastasis or growth of a tumor cell'
[patent_app_type] => new
[patent_app_number] => 10/706265
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13023
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132642.pdf
[firstpage_image] =>[orig_patent_app_number] => 10706265
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/706265 | Methods of inhibiting metastasis or growth of a tumor cell | Nov 11, 2003 | Abandoned |